{
    "2019-04-04": [
        [
            {
                "time": "2019-04-04",
                "original_text": "Oklahoma drops some claims against opioid manufacturers",
                "features": {
                    "keywords": [
                        "Oklahoma",
                        "drops",
                        "opioid",
                        "manufacturers"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-04-04",
                "original_text": "Oklahoma drops several claims in opioid case against J&J, Teva",
                "features": {
                    "keywords": [
                        "Oklahoma",
                        "drops",
                        "opioid",
                        "case",
                        "J&J",
                        "Teva"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-04-04",
                "original_text": "Editas (EDIT) Inks Cross Licensing Agreement with BlueRock",
                "features": {
                    "keywords": [
                        "Editas",
                        "cross",
                        "licensing",
                        "agreement",
                        "BlueRock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-04-04",
                "original_text": "Dow Movers: WBA, DOW",
                "features": {
                    "keywords": [
                        "Dow",
                        "Movers",
                        "WBA",
                        "DOW"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-04",
                "original_text": "IVV, JNJ, JPM, PG: Large Inflows Detected at ETF",
                "features": {
                    "keywords": [
                        "IVV",
                        "JNJ",
                        "JPM",
                        "PG",
                        "ETF",
                        "inflows"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-04",
                "original_text": "STATELINE-Opioid Crisis ‘Kingpin’ Is Oklahoma’s New Target in Lawsuit",
                "features": {
                    "keywords": [
                        "Oklahoma",
                        "opioid",
                        "crisis",
                        "lawsuit"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-04-04",
                "original_text": "Health Care Sector Update for 04/04/2019: NSPR, REPH, RWLK, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update",
                        "NSPR",
                        "REPH",
                        "RWLK",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-04",
                "original_text": "Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "Stock",
                        "Sinks",
                        "Market",
                        "Gains"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}